|
|
Article: New thrombosis research presented at CHEST 2009.
- Article from:
- NewsRx Health
- Article date:
- November 22, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Extended Therapy for Blood Clot Prevention Yields Greater Benefits in Hip/Knee Surgery (#8587, Monday, November 2, 5:30 PM ET)
Patients undergoing total knee replacement (TKR) or total hip replacement (THR) surgeries may experience better outcomes if they receive extended therapy for the prevention of thrombosis (blood clots). Researchers from the University of Ottawa, ON, and Ortho-McNeil Pharmaceutical found that 2,140 patients undergoing TKR or THR who received short-duration (14 days) thromboprophylaxis experienced three times as many venous thromboembolism events, two times as many DVT events, six times as many pulmonary embolism events, and four times more ...